Found 61 hits with Last Name = 'stachew' and Initial = 'cf' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133557
(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-morphol...)Show InChI InChI=1S/C15H16Cl2N4O2S/c16-11-2-1-3-12(17)10(11)8-14-18-13(9-24-14)19-15(22)20-21-4-6-23-7-5-21/h1-3,9H,4-8H2,(H2,19,20,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| 500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Inhibition of Tau Protein Kinase II (TPK II) |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133573
(CHEMBL119530 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C17H13Cl2N3O2S/c18-13-7-4-8-14(19)12(13)9-16-20-15(10-25-16)21-17(23)22-24-11-5-2-1-3-6-11/h1-8,10H,9H2,(H2,21,22,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133557
(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-morphol...)Show InChI InChI=1S/C15H16Cl2N4O2S/c16-11-2-1-3-12(17)10(11)8-14-18-13(9-24-14)19-15(22)20-21-4-6-23-7-5-21/h1-3,9H,4-8H2,(H2,19,20,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133579
(CHEMBL117950 | N-(tert-butoxy)-N'-[2-(2,6-dichloro...)Show InChI InChI=1S/C15H17Cl2N3O2S/c1-15(2,3)22-20-14(21)19-12-8-23-13(18-12)7-9-10(16)5-4-6-11(9)17/h4-6,8H,7H2,1-3H3,(H2,19,20,21) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133564
(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-pyrroli...)Show InChI InChI=1S/C15H16Cl2N4OS/c16-11-4-3-5-12(17)10(11)8-14-18-13(9-23-14)19-15(22)20-21-6-1-2-7-21/h3-5,9H,1-2,6-8H2,(H2,19,20,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133575
(CHEMBL119041 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C16H17Cl2N3O3S/c17-11-4-3-5-12(18)10(11)8-14-19-13(9-25-14)20-16(22)21-24-15-6-1-2-7-23-15/h3-5,9,15H,1-2,6-8H2,(H2,20,21,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133551
(CHEMBL119143 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C13H14Cl2N4OS/c1-19(2)18-13(20)17-11-7-21-12(16-11)6-8-9(14)4-3-5-10(8)15/h3-5,7H,6H2,1-2H3,(H2,17,18,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133569
(1-Morpholin-4-yl-3-[2-(pyridine-2-sulfonylmethyl)-...)Show InChI InChI=1S/C14H17N5O4S2/c20-14(18-19-5-7-23-8-6-19)17-11-9-24-12(16-11)10-25(21,22)13-3-1-2-4-15-13/h1-4,9H,5-8,10H2,(H2,17,18,20) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133580
(CHEMBL119796 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C13H13Cl2N3O2S/c1-2-20-18-13(19)17-11-7-21-12(16-11)6-8-9(14)4-3-5-10(8)15/h3-5,7H,2,6H2,1H3,(H2,17,18,19) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133566
(CHEMBL117778 | N-{2-[(methylsulfonyl)methyl]-1,3-t...)Show InChI InChI=1S/C12H13N3O4S2/c1-21(17,18)8-11-13-10(7-20-11)14-12(16)15-19-9-5-3-2-4-6-9/h2-7H,8H2,1H3,(H2,14,15,16) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133567
(CHEMBL118685 | N-(allyloxy)-N'-[2-(2,6-dichloroben...)Show InChI InChI=1S/C14H13Cl2N3O2S/c1-2-6-21-19-14(20)18-12-8-22-13(17-12)7-9-10(15)4-3-5-11(9)16/h2-5,8H,1,6-7H2,(H2,18,19,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133556
(1-Morpholin-4-yl-3-(2-phenyl-thiazol-4-yl)-urea | ...)Show InChI InChI=1S/C14H16N4O2S/c19-14(17-18-6-8-20-9-7-18)16-12-10-21-13(15-12)11-4-2-1-3-5-11/h1-5,10H,6-9H2,(H2,16,17,19) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133555
(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-piperid...)Show InChI InChI=1S/C16H18Cl2N4OS/c17-12-5-4-6-13(18)11(12)9-15-19-14(10-24-15)20-16(23)21-22-7-2-1-3-8-22/h4-6,10H,1-3,7-9H2,(H2,20,21,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133576
(CHEMBL116615 | N-phenoxy-N'-(2-phenyl-1,3-thiazol-...)Show InChI InChI=1S/C16H13N3O2S/c20-16(19-21-13-9-5-2-6-10-13)18-14-11-22-15(17-14)12-7-3-1-4-8-12/h1-11H,(H2,18,19,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 8.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133549
(CHEMBL117800 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C12H11Cl2N3O2S/c1-19-17-12(18)16-10-6-20-11(15-10)5-7-8(13)3-2-4-9(7)14/h2-4,6H,5H2,1H3,(H2,16,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 9.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133556
(1-Morpholin-4-yl-3-(2-phenyl-thiazol-4-yl)-urea | ...)Show InChI InChI=1S/C14H16N4O2S/c19-14(17-18-6-8-20-9-7-18)16-12-10-21-13(15-12)11-4-2-1-3-5-11/h1-5,10H,6-9H2,(H2,16,17,19) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 9.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133551
(CHEMBL119143 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C13H14Cl2N4OS/c1-19(2)18-13(20)17-11-7-21-12(16-11)6-8-9(14)4-3-5-10(8)15/h3-5,7H,6H2,1-2H3,(H2,17,18,20) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133559
(1-Morpholin-4-yl-3-(2-thiophen-2-yl-thiazol-4-yl)-...)Show InChI InChI=1S/C12H14N4O2S2/c17-12(15-16-3-5-18-6-4-16)14-10-8-20-11(13-10)9-2-1-7-19-9/h1-2,7-8H,3-6H2,(H2,14,15,17) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133574
(1-Azepan-1-yl-3-[2-(2,6-dichloro-benzyl)-thiazol-4...)Show InChI InChI=1S/C17H20Cl2N4OS/c18-13-6-5-7-14(19)12(13)10-16-20-15(11-25-16)21-17(24)22-23-8-3-1-2-4-9-23/h5-7,11H,1-4,8-10H2,(H2,21,22,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133557
(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-morphol...)Show InChI InChI=1S/C15H16Cl2N4O2S/c16-11-2-1-3-12(17)10(11)8-14-18-13(9-24-14)19-15(22)20-21-4-6-23-7-5-21/h1-3,9H,4-8H2,(H2,19,20,22) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133569
(1-Morpholin-4-yl-3-[2-(pyridine-2-sulfonylmethyl)-...)Show InChI InChI=1S/C14H17N5O4S2/c20-14(18-19-5-7-23-8-6-19)17-11-9-24-12(16-11)10-25(21,22)13-3-1-2-4-15-13/h1-4,9H,5-8,10H2,(H2,17,18,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133565
(CHEMBL116339 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show SMILES CN(NC(=O)Nc1csc(Cc2c(Cl)cccc2Cl)n1)c1ccccc1 Show InChI InChI=1S/C18H16Cl2N4OS/c1-24(12-6-3-2-4-7-12)23-18(25)22-16-11-26-17(21-16)10-13-14(19)8-5-9-15(13)20/h2-9,11H,10H2,1H3,(H2,22,23,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133568
(1-[2-(2-Chloro-phenyl)-thiazol-4-yl]-3-morpholin-4...)Show InChI InChI=1S/C14H15ClN4O2S/c15-11-4-2-1-3-10(11)13-16-12(9-22-13)17-14(20)18-19-5-7-21-8-6-19/h1-4,9H,5-8H2,(H2,17,18,20) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133579
(CHEMBL117950 | N-(tert-butoxy)-N'-[2-(2,6-dichloro...)Show InChI InChI=1S/C15H17Cl2N3O2S/c1-15(2,3)22-20-14(21)19-12-8-23-13(18-12)7-9-10(16)5-4-6-11(9)17/h4-6,8H,7H2,1-3H3,(H2,19,20,21) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133560
(CHEMBL117779 | N-[2-(3-methylphenyl)-1,3-thiazol-4...)Show InChI InChI=1S/C17H15N3O2S/c1-12-6-5-7-13(10-12)16-18-15(11-23-16)19-17(21)20-22-14-8-3-2-4-9-14/h2-11H,1H3,(H2,19,20,21) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133550
(1-[2-(4-Methoxy-phenoxymethyl)-thiazol-4-yl]-3-mor...)Show InChI InChI=1S/C16H20N4O4S/c1-22-12-2-4-13(5-3-12)24-10-15-17-14(11-25-15)18-16(21)19-20-6-8-23-9-7-20/h2-5,11H,6-10H2,1H3,(H2,18,19,21) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133553
(1-Morpholin-4-yl-3-(2-m-tolyl-thiazol-4-yl)-urea |...)Show InChI InChI=1S/C15H18N4O2S/c1-11-3-2-4-12(9-11)14-16-13(10-22-14)17-15(20)18-19-5-7-21-8-6-19/h2-4,9-10H,5-8H2,1H3,(H2,17,18,20) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133564
(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-pyrroli...)Show InChI InChI=1S/C15H16Cl2N4OS/c16-11-4-3-5-12(17)10(11)8-14-18-13(9-23-14)19-15(22)20-21-6-1-2-7-21/h3-5,9H,1-2,6-8H2,(H2,19,20,22) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133580
(CHEMBL119796 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C13H13Cl2N3O2S/c1-2-20-18-13(19)17-11-7-21-12(16-11)6-8-9(14)4-3-5-10(8)15/h3-5,7H,2,6H2,1H3,(H2,17,18,19) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133552
(CHEMBL325452 | N-(2-benzyl-1,3-thiazol-4-yl)-N'-ph...)Show InChI InChI=1S/C17H15N3O2S/c21-17(20-22-14-9-5-2-6-10-14)19-15-12-23-16(18-15)11-13-7-3-1-4-8-13/h1-10,12H,11H2,(H2,19,20,21) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133577
(1-Morpholin-4-yl-3-(2-phenylsulfanylmethyl-thiazol...)Show InChI InChI=1S/C15H18N4O2S2/c20-15(18-19-6-8-21-9-7-19)17-13-10-23-14(16-13)11-22-12-4-2-1-3-5-12/h1-5,10H,6-9,11H2,(H2,17,18,20) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133559
(1-Morpholin-4-yl-3-(2-thiophen-2-yl-thiazol-4-yl)-...)Show InChI InChI=1S/C12H14N4O2S2/c17-12(15-16-3-5-18-6-4-16)14-10-8-20-11(13-10)9-2-1-7-19-9/h1-2,7-8H,3-6H2,(H2,14,15,17) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133577
(1-Morpholin-4-yl-3-(2-phenylsulfanylmethyl-thiazol...)Show InChI InChI=1S/C15H18N4O2S2/c20-15(18-19-6-8-21-9-7-19)17-13-10-23-14(16-13)11-22-12-4-2-1-3-5-12/h1-5,10H,6-9,11H2,(H2,17,18,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133568
(1-[2-(2-Chloro-phenyl)-thiazol-4-yl]-3-morpholin-4...)Show InChI InChI=1S/C14H15ClN4O2S/c15-11-4-2-1-3-10(11)13-16-12(9-22-13)17-14(20)18-19-5-7-21-8-6-19/h1-4,9H,5-8H2,(H2,17,18,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133553
(1-Morpholin-4-yl-3-(2-m-tolyl-thiazol-4-yl)-urea |...)Show InChI InChI=1S/C15H18N4O2S/c1-11-3-2-4-12(9-11)14-16-13(10-22-14)17-15(20)18-19-5-7-21-8-6-19/h2-4,9-10H,5-8H2,1H3,(H2,17,18,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133550
(1-[2-(4-Methoxy-phenoxymethyl)-thiazol-4-yl]-3-mor...)Show InChI InChI=1S/C16H20N4O4S/c1-22-12-2-4-13(5-3-12)24-10-15-17-14(11-25-15)18-16(21)19-20-6-8-23-9-7-20/h2-5,11H,6-10H2,1H3,(H2,18,19,21) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133555
(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-piperid...)Show InChI InChI=1S/C16H18Cl2N4OS/c17-12-5-4-6-13(18)11(12)9-15-19-14(10-24-15)20-16(23)21-22-7-2-1-3-8-22/h4-6,10H,1-3,7-9H2,(H2,20,21,23) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133576
(CHEMBL116615 | N-phenoxy-N'-(2-phenyl-1,3-thiazol-...)Show InChI InChI=1S/C16H13N3O2S/c20-16(19-21-13-9-5-2-6-10-13)18-14-11-22-15(17-14)12-7-3-1-4-8-12/h1-11H,(H2,18,19,20) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133567
(CHEMBL118685 | N-(allyloxy)-N'-[2-(2,6-dichloroben...)Show InChI InChI=1S/C14H13Cl2N3O2S/c1-2-6-21-19-14(20)18-12-8-22-13(17-12)7-9-10(15)4-3-5-11(9)16/h2-5,8H,1,6-7H2,(H2,18,19,20) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 4.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133554
(1-(2-Benzyl-thiazol-4-yl)-3-morpholin-4-yl-urea | ...)Show InChI InChI=1S/C15H18N4O2S/c20-15(18-19-6-8-21-9-7-19)17-13-11-22-14(16-13)10-12-4-2-1-3-5-12/h1-5,11H,6-10H2,(H2,17,18,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 5.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133565
(CHEMBL116339 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show SMILES CN(NC(=O)Nc1csc(Cc2c(Cl)cccc2Cl)n1)c1ccccc1 Show InChI InChI=1S/C18H16Cl2N4OS/c1-24(12-6-3-2-4-7-12)23-18(25)22-16-11-26-17(21-16)10-13-14(19)8-5-9-15(13)20/h2-9,11H,10H2,1H3,(H2,22,23,25) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 6.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133574
(1-Azepan-1-yl-3-[2-(2,6-dichloro-benzyl)-thiazol-4...)Show InChI InChI=1S/C17H20Cl2N4OS/c18-13-6-5-7-14(19)12(13)10-16-20-15(11-25-16)21-17(24)22-23-8-3-1-2-4-9-23/h5-7,11H,1-4,8-10H2,(H2,21,22,24) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 7.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133561
(1-Morpholin-4-yl-3-(2-phenoxymethyl-thiazol-4-yl)-...)Show InChI InChI=1S/C15H18N4O3S/c20-15(18-19-6-8-21-9-7-19)17-13-11-23-14(16-13)10-22-12-4-2-1-3-5-12/h1-5,11H,6-10H2,(H2,17,18,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133566
(CHEMBL117778 | N-{2-[(methylsulfonyl)methyl]-1,3-t...)Show InChI InChI=1S/C12H13N3O4S2/c1-21(17,18)8-11-13-10(7-20-11)14-12(16)15-19-9-5-3-2-4-6-9/h2-7H,8H2,1H3,(H2,14,15,16) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 9.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133575
(CHEMBL119041 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C16H17Cl2N3O3S/c17-11-4-3-5-12(18)10(11)8-14-19-13(9-25-14)20-16(22)21-24-15-6-1-2-7-23-15/h3-5,9,15H,1-2,6-8H2,(H2,20,21,22) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 9.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133573
(CHEMBL119530 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C17H13Cl2N3O2S/c18-13-7-4-8-14(19)12(13)9-16-20-15(10-25-16)21-17(23)22-24-11-5-2-1-3-6-11/h1-8,10H,9H2,(H2,21,22,23) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133582
(1-Morpholin-4-yl-3-(2-p-tolyl-thiazol-4-yl)-urea |...)Show InChI InChI=1S/C15H18N4O2S/c1-11-2-4-12(5-3-11)14-16-13(10-22-14)17-15(20)18-19-6-8-21-9-7-19/h2-5,10H,6-9H2,1H3,(H2,17,18,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133563
(1-(2-Ethyl-thiazol-4-yl)-3-morpholin-4-yl-urea | C...)Show InChI InChI=1S/C10H16N4O2S/c1-2-9-11-8(7-17-9)12-10(15)13-14-3-5-16-6-4-14/h7H,2-6H2,1H3,(H2,12,13,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133581
(1-[2-(4-Chloro-phenyl)-thiazol-4-yl]-3-morpholin-4...)Show InChI InChI=1S/C14H15ClN4O2S/c15-11-3-1-10(2-4-11)13-16-12(9-22-13)17-14(20)18-19-5-7-21-8-6-19/h1-4,9H,5-8H2,(H2,17,18,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133549
(CHEMBL117800 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C12H11Cl2N3O2S/c1-19-17-12(18)16-10-6-20-11(15-10)5-7-8(13)3-2-4-9(7)14/h2-4,6H,5H2,1H3,(H2,16,17,18) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |